
CARDINAL HEALTH INC
CAHNYSETrading Snapshot
- Day Range
- $237.98 โ $242.08
- 52-Week Range
- $137.75 โ $244.87
- Volume
- $2.42B
- Avg Volume
- $2.98B
- Shares Outstanding
- 234.2M
- Next Earnings
- Oct 7, 2026
Fundamentals Snapshot
- Annual Revenue
- $63.67B
- Last Q Revenue
- $60.94B
- P/E Ratio
- 35.6
- P/S Ratio
- 0.2x
- EPS (TTM)
- $6.54
- Dividend Yield
- 0.89%
Why Investors Own CAH
- โHigh-growth profile โ revenue up -1.0% YoY with expanding US Equity exposure.
- โHealthy economics โ 77% gross margin and 21% free-cash-flow margin.
- โNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About CARDINAL HEALTH INC
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
Otter Score Breakdown
โAnalyst Ratings
โLatest News & Updates

Cardinal Health, Inc. (CAH) Q4 2026 Earnings Call Transcript
Cardinal Health, Inc. (CAH) Q4 2026 Earnings Call August 11, 2026 8:30 AM EDTCompany ParticipantsDavid Frost - Vice President of Finance, Global Operations...

ValuEngine Weekly Market Summary And Commentary
U.S. equity markets rebounded strongly this week, with gains led by technology and growth-oriented sectors.

Cardinal Health Says It Now Exclusively Serves Nearly Half The Cell-And-Gene Therapy Market
CAH stock hits new 52-week high as Cardinal Health beats Q4 earnings, boosts FY27 outlook, and approves a $5B buyback expansion.

US Stocks Mixed; Cardinal Health Shares Jump After Q4 Results
US stocks mixed, Dow up 150 points. Industrials gain 1%, communication services fall 1.1%. Cardinal Health (NYSE: CAH) up 8%. Oil up 0.4%, gold up 0.6%.

Cardinal Health, Inc. 2026 Q4 - Results - Earnings Call Presentation
2026-08-11. The following slide deck was published by Cardinal Health, Inc.

Stocks making the biggest moves premarket: Riot Platforms, Hims & Hers Health, Intel & more
These are the stocks posting the largest moves premarket.